Clinical Trial Update: Injections of Glutamic Acid Decarboxylase (GAD) for LADA Type of Diabetes [Phase 2]

View source ↗

Summary

Phase 2 study results for injections of glutamic acid decarboxylase (GAD) for latent autoimmune diabetes in adults (LADA) have been posted after completion of t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Autoimmune Diabetes in Adults

Drugs mentioned

• Glutamic Acid Decarboxylase injections (glutamic acid decarboxylase)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Latent Autoimmune Diabetes in Adults | Phase 2 | Status: COMPLETED | Results posted: 2025-06-08